Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
NCT ID: NCT06059313
Last Updated: 2023-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
120 participants
OBSERVATIONAL
2023-10-01
2027-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will assess the relationship between premorbid profile using NEO-PI 3 inventory and cognitive and behavioral/psychobehavioral manifestations in patients with behavioral variant of frontotemporal disorder (bvFTD), phenocopy frontotemporal dementia (phFTD), frontal variant of Alzheimer disease, bipolar disorder characterized with frontal damages.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploration of Neural Bases in Social Cognition
NCT02110017
Clinical Determinants of the Discrepancy Between Objective and Subjective Cognition in the Versailles FACE-BD Cohort
NCT04034147
Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study
NCT01821469
Connectomics in Psychiatric Classification
NCT03967535
Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin
NCT06463093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behavioral variant of frontotemporal disorder (bvFTD)
A group of participants who fulfill Rascovsky criteria (2011) for behavioural variant Frontotemporal Dementia
Submission of the NEO-PI-3 questionnaire
The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).
Submission of the Interpersonal Reactivity Index questionnaire (IRI)
The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.
Phenocopy frontotemporal dementia (phFTD)
A group of participants who fulfill who fulfill Rascovsky criteria (2011) for possible behavioural variant Frontotemporal Dementia and have no imaging abnormalities.
Submission of the NEO-PI-3 questionnaire
The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).
Submission of the Interpersonal Reactivity Index questionnaire (IRI)
The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.
Frontal variant of Alzheimer disease
A group of participants who fulfill Ossenkopele criteria (2022)
Submission of the NEO-PI-3 questionnaire
The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).
Submission of the Interpersonal Reactivity Index questionnaire (IRI)
The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.
Bipolar disorder
A group of participants who fulfill CIM 10 criteria
Submission of the NEO-PI-3 questionnaire
The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).
Submission of the Interpersonal Reactivity Index questionnaire (IRI)
The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Submission of the NEO-PI-3 questionnaire
The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).
Submission of the Interpersonal Reactivity Index questionnaire (IRI)
The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score for Mini-mental state examination ≥ 18
* Patient with caregiver who has who has known him/her in the 10 years preceding the disease onset.
* Patient and caregiver consents (no opposition)
Exclusion Criteria
* Pregnant or breast feeding women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC23_0343
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.